Malgorzata Romanik

Dr. Malgorzata Romanik


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2026 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
MNMagdalena Namysł
Magdalena Namysł
MSMagdalena Skóra
Magdalena Skóra
MPMonika Pomorska-Wesołowska
Monika Pomorska-Wesołowska
MRMalgorzata Romanik
Malgorzata Romanik
WŚWioletta Świątek-Kwapniewska
Wioletta Świątek-Kwapniewska
Jadwiga Wójkowska-MachJadwiga Wójkowska-Mach
Jadwiga Wójkowska-Mach
Candida fungi are among the most common human fungal pathogens and invasive candidiasis is one of the predominant invasive mycoses that mainly affects hospitalized patients with suppression of the immunological system and breaches in skin or mucosal barriers. Rapid diagnosis and implementation of appropriate antifungal treatment are key to achieving recovery. In recent years, attention has been drawn to the increasing significance of Candida species other than C. albicans, in particular C. auris and fluconazole-resistant C. parapsilosis. The aim of this work was to present the species spectrum and drug susceptibility of 570 Candida strains isolated from candidemia cases diagnosed in patients hospitalized in southern Poland in the period 2017–2022. The results of Candida-positive blood cultures obtained from five hospitals were analyzed. C. albicans was the most common species, accounting for 42.6% of all strains, followed by Nakaseomyces glabratus (formerly C. glabrata) and C. parapsilosis complex—22.1% and 18.8%, respectively. No C. auris was found. Fluconazole resistance was found in 4.9% of C. albicans strains, 34.7% of N. glabratus strains, and 8.7% of C. parapsilosis complex strains.

12 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ADAgata Izabela Dziedzic-Kowalska
Agata Izabela Dziedzic-Kowalska
KSKarolina Strzelec
Karolina Strzelec
KFKlara Ferenc
Klara Ferenc
MRMalgorzata Romanik
Malgorzata Romanik
MAMalgorzata Aptekorz
Malgorzata Aptekorz
KGKatarzyna Gawron
Katarzyna Gawron
This study compared immune activation of gingival fibroblasts (GFs) by Porphyromonas gingivalis strains carrying different variants of peptidylarginine deiminase (PPAD). To this aim, GFs from donors with periodontitis (PD) (n=4) and healthy controls (CTRL) (n=2) were infected with P. gingivalis strains expressing either ppad with missense mutations (A390T + T421I) (n=2, moderate PD) or clusters of specific polymorphic variants (S203P + G231N, E232T, N235D) and (S203P + G231N, E232T, N235D + N291D + A515V + S528G) (n=2, advanced PD). Enzymatic activity of PPAD from these strains was determined using a colorimetric assay. Immune activation of infected GFs was analysed using qRT-PCR. P. gingivalis strains carrying clusters of specific polymorphic variants of ppad induced ~two-fold increase of PPAD activity and upregulated TNF-α, IL-6, and COX-2 expression by infected GFs compared to the reference ATCC 33277 strain. Contrary, P. gingivalis strains containing missense mutations showed decreased PPAD activity and elicited inflammatory response comparable to that presented by the ATCC 33277 strain. This study demonstrated that the inflammatory outcome of P. gingivalis infection results from the interplay between bacterial virulence driven by PPAD sequence diversity and enzymatic activity, and the intrinsic hyperreactivity of host GFs associated with PD.